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Abstract
One of the possible causes of disturbed circadian rhythms and sleep in the elderly may be impaired photic input to the circadian clock.
Age-related changes in lens density are known to reduce the transmission of short wavelength light, which has been shown to be most
effective in suppressing nocturnal melatonin. The aim of the study therefore was to investigate age-related changes in melatonin suppression
in response to short and medium wavelength light.
Young premenopausal (nZ13) and postmenopausal (nZ21) women were exposed to 30 min of monochromatic light at two different
wavelengths and irradiances (lmax 456 nm: 3.8 and 9.8 mW/cm
2; lmax 548 nm: 28 and 62 mW/cm
2). Melatonin suppression was compared
across light treatments and between age groups.
Significantly reduced melatonin suppression was noted in the elderly subjects following exposure to short wavelength (456 nm) light
compared to the young subjects. These results are likely to reflect age-related changes in lens density.
q 2004 Elsevier Inc. All rights reserved.
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The spectral sensitivity of the ability of light to suppress
nocturnal melatonin in humans has been investigated and
two action spectra constructed (Brainard et al., 2001;
Thapan et al., 2001). These action spectra show distinct
short wavelength sensitivity, identifying 457–464 nm as the
most potent wavelength in suppressing nocturnal melatonin
synthesis. Recent research also demonstrates that the ability
of light to phase advance (Warman et al., 2003) and phase
delay (Lockley et al., 2003) circadian rhythms shows a
similar short wavelength sensitivity.
Many studies have reported age-related alterations in
different components of the circadian system (reviewed by
Van Someren, 2000; Skene and Swaab, 2003). Of particular
relevance to age-related changes in photic entrainment are
changes in the ageing eye. There are a number of age-related
changes in the eye that may contribute to reduced levels of0531-5565/$ - see front matter q 2004 Elsevier Inc. All rights reserved.
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E-mail address: d.skene@surrey.ac.uk (D.J. Skene).light reaching the retina, such as the reduction in pupil size
(Verriest, 1971) and changes within the crystalline lens
(Weale, 1985). These changes would reduce the amount of
light input to the circadian clock located in the suprachias-
matic nuclei (SCN) of the hypothalamus. Within the
crystalline lens accumulation of high molecular weight
crystallin aggregates (Jedziniak et al., 1973; Yu et al., 1985)
and yellow chromophores (Dillon and Atherton, 1990)
cause an increase in light scattering and light absorption,
respectively. As a result the density of the lens increases
with ageing (Weale, 1954; Coren and Girgus, 1972; Xu
et al., 1997) causing an alteration in the spectral absorption.
The greatest increase in absorption occurs at the short
wavelength end of the spectrum (around 400–470 nm)
(Said and Weale, 1959; Norren and Vos, 1974; Smith and
Pokorny, 1975). Furthermore with ageing, the lens darkens
and develops a yellow pigmentation that further reduces
light transmission to the retina (Lerman et al., 1976; Garner
et al., 1999). These age-related changes in the eye may
affect photic entrainment of the circadian clock and may
in part explain some of the changes in circadianExperimental Gerontology 40 (2005) 237–242www.elsevier.com/locate/expgero
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elderly (Bliwise, 1993; Duffy et al., 1998; Dijk and Duffy,
1999; Ancoli-Israel, 2000).
As short wavelength light has been found to be the
most effective in suppressing nocturnal plasma melatonin
(Brainard et al., 2001; Thapan et al., 2001) and as
transmission of this short wavelength light is reduced with
ageing, it might be expected that the melatonin response to
short wavelength light is reduced in older people. This
hypothesis, however, has not yet been tested. A short report
(Nathan et al., 1999) showed that suppression of melatonin
by exposure to 200 lux white light was not affected by age.
In this study, no significant difference was noted in
melatonin suppression between three age groups, the oldest
age group being 41.7G2 years (meanGSEM). To date,
however, the effects of monochromatic short wavelength
light on melatonin suppression have not been studied in
the elderly.
The aim of the present study was to investigate the effect
of age on the ability of short (456 nm) and medium
(548 nm) wavelength light to suppress nocturnal melatonin.
If the melatonin response is dependent on the age-related
change in the spectral density of the lens, then it would be
expected that there would be a significantly reduced
response to the short wavelength light in the older group,
whereas the response to the medium wavelength light would
not differ significantly between the two age groups. Light
intensities were chosen to give submaximal suppression of
nocturnal plasma melatonin, according to our earlier data
(Thapan et al., 2001).2. Methods
2.1. Subjects
In total, 41 subjects were recruited onto the study but four
subjects withdrew during the study and three subjects had to
be excluded from the data analysis due to low, undetectable
plasma melatonin levels. Two groups of subjects, young
(nZ13, aged 24G3 years, meanGSD) and postmenopausal
(nZ21, aged 57G5 years) women were included in the
analysis. All subjects gave informed consent and the
University of Surrey Ethics Committee approved the study.
The menopausal status of the postmenopausal women
was defined by a minimum of 12 months without
menstruation and was confirmed by blood hormone analysis
(follicle stimulating hormone 22–153 IU/L, lutenising
hormone 11–40 IU/L, oestradiol !200 pmol/L). All sub-
jects were free of any medication known to affect the
melatonin rhythm (b-blockers, calcium channel blockers,
a-blockers, non steroidal anti-inflammatory drugs, benzo-
diazepines, antidepressants, hypnotic drugs, antipsychotics,
barbiturates and antiepileptic drugs). All young subjects
were taking oral contraceptives. None of the postmenopau-
sal women were taking hormone replacement therapy(HRT). Subjects underwent an extensive ophthalmological
examination and were free of ocular disorders (glaucoma,
cataracts, colour defects).
2.2. Study protocol
Preceding the clinical laboratory study, the subjects’
endogenous melatonin rhythm was assessed by measuring
urinary 6-sulphatoxymelatonin (aMT6s). The time of light
administration was standardised so that each individual
received light on the rising phase of their endogenous
melatonin rhythm. This was estimated from an individual’s
aMT6s peak time, light being given 2.5–4.5 h before the
aMT6s peak. Three days before commencement of the
clinical study subjects were asked to keep a regular
sleep–wake schedule (23:00–07:00 h). Daily sleep diaries
and monitoring of the subjects’ activity and light exposure
by Actiwatch recordings (AWL, Cambridge Neurotechno-
logy Ltd, UK) confirmed compliance. The subjects were
instructed to avoid alcohol, caffeine, excessive exercise and
bright light 24 h before the clinical study to minimise
factors known to affect circadian phase.
The study consisted of two 3-night sessions separated by
at least 5 days. Night 1 (N1) of each session was a baseline
night (18:00–07:00 h) with no light exposure. Blood
samples for dim light melatonin onset (DLMO) were
collected every 30 min on N1 (20:00–23:00 h). The baseline
night (N1) was followed by two light exposure nights
(N2 and N3) with each subject being exposed to 30 min of
monochromatic light at two different wavelengths and
irradiances (lmax 456 nm: 3.8 and 9.8 mW/cm
2; lmax
548 nm: 28 and 62 mW/cm2). On N2 subjects were exposed
to the lower irradiance of the selected light wavelength
followed by the higher irradiance on N3. The same 3-night
protocol was repeated in a second session with the other
light wavelength. The order of light wavelength exposure
(lmax 456 or 548 nm) was randomised between subjects.
Posture and environmental light were controlled
throughout the study (N1-19:00–23:00 h; N2 and
N3-21:00–23:00 h: dim light !5 lux: 2 lux in the angle of
gaze and 4–5 lux when looking directly at the overhead
white lights; 23:00–07:00 h: 0 lux, complete darkness with
subjects wearing eye masks). Pupil size was controlled with
one drop of a short acting pupil dilator, Tropicamide 0.5%
(Chauvin Pharmaceuticals, Romford, UK) administered to
each eye 90 min before the light exposure. On each night of
the study session (N1–N3) blood samples were taken via an
indwelling cannula at K90, K15, 0, 15, 30, 45, 60, 75, 90
and 120 min around the light exposure (0 min was onset of
light exposure).
2.3. Sample analysis
Plasma melatonin was assessed by radioimmunoassay
(Fraser et al., 1983) with reagents supplied by
Stockgrand Ltd (University of Surrey, Guildford, UK).
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4.6G0.2 pg/ml (meanGSEM). The interassay coefficients
of variation (CV) were 15% at 26 pg/ml (nZ46), 18% at
54 pg/ml (nZ38), 14% at 139 pg/ml (nZ27) and 9% at
235 pg/ml (nZ12).
2.4. Light exposure
The light pulse was produced by a metal halide (a mixture
of metal halide with high doses of InI and T1I) arc lamp
housed in a fan cooling box (Enlightened Technology
Associates Inc., Fairfax, USA). This produced a beam of
white light that was delivered to a sphere (45 cm diameter)
via a fibre optic cable. The white light was filtered to a
specific wavelength using monochromatic filters. The visible
bandpass monochromatic filters (Coherent Ealing, Watford,
UK) were constructed from multi-cavity dielectric on
borosilicate glass. The spectral quality of the monochromatic
filters was altered slightly from the manufacturer’s specifica-
tions due to the design of the sphere. Spectroradiometer
(Spectrascan 650, Photoresearch, Chatsworth, CA, USA)
measurements confirmed the lmax wavelengths at eye level to
be 456 and 548 nm instead of 460 and 560 nm, respectively.
Subjects were exposed to the monochromatic light (full
width at half maximum (FWHM)%13 nm) by placing their
heads into the sphere. The sphere was coated with white
reflectance paint (Kodak, Hemel Hempstead, UK) providing
constant uniform illumination of the entire retina. An
adjustable chin rest and head band ensured a fixed eye level
with the gaze directed to a dot centred at the back of the
sphere. Light irradiance (mW/cm2) was measured at the
subject’s eye level (optical powermeter, Macam Photo-
metrics, Livingstone, UK). Each irradiance measured was
corrected for the specific light wavelength using calibrated
correction factors (456 nm: 0.836 and 548 nm: 0.982).
Subjects were exposed to two different wavelengths and
irradiances of light (lmax 456 nm: 3.8 and 9.8 mW/cm
2; lmax
548 nm: 28 and 62 mW/cm2) of different photon densities
(lmax 456 nm: 8.7!10
12 and 2.2!1013 photons/cm2/s; lmax
548 nm: 7.7!1013 and 1.7!1014 photons/cm2/s).
2.5. Data analysis
Suppression of plasma melatonin (%) was calculated by
comparing the mean melatonin concentrations at 30 and
45 min after commencement of light administration (points
of maximum melatonin suppression) with the melatonin
concentration before light administration (0 min). The area
under the curve (AUC) of the percentage melatonin
suppression (0–45 min) was also calculated. Two-way
repeated measures analysis of variance (ANOVA) was
used to determine the effect of light treatment and age on
melatonin suppression (Statistica, Statsoft Ltd, Bedford,
UK). In view of our hypothesis (age-related changes in lens
density would reduce the response to 456 nm light but not to
548 nm light) the two wavelengths of light were analysedseparately. Significant results were further analysed post
hoc using Tukey Honestly Significant Difference (HSD)
test. Two postmenopausal subjects had to be excluded from
the analysis due to missing blood samples for one of the
light conditions. Due to poor repeatability of the melatonin
profile between the baseline night and light treatment nights
(15/32 subjects had baseline values differing by more than
20% in at least one light condition), baseline N1 values were
not included in the calculation of melatonin suppression as
this would produce an inaccurate estimation of melatonin
suppression.
Average spectral lens density calculations for
each individual were done in accordance with the Pokorny
et al. (1987) two-factor non-linear lens density spectrum
model. In this model, the optical density of the total lens
transmission (TL) is separated into two components which
are light-wavelength dependent, (i) portion of the lens
affected by ageing after the age of 20 (TL1) and (ii) stable
portion after the age of 20 (TL2). Using this model average
spectral lens density was estimated for adults aged 20–80
years for completely open (O7 mm) pupils.3. Results
Preceding the clinical study, analysis of urinary aMT6s
showed that the young women had significantly higher 24 h
aMT6s production (22.6G2.6 mg/24 h, meanGSEM) com-
pared to the postmenopausal women (12.4G1.5 mg/24 h
p!0.05, unpaired Student’s t-test). Furthermore, the
postmenopausal women had significantly earlier aMT6s
peak times (4.0G0.3 h) than the young women (5.0G0.2 h,
p!0.05).
Fig. 1 shows the time course of melatonin suppression in
the young and postmenopausal women following the four
different light treatments. Maximal suppression of melatonin
occurred 30 and 45 min after the start of light exposure.
Melatonin levels returned to baseline values 30–60 min after
lights off depending on the intensity of the light.
Melatonin suppression (meanGSEM) for each light
treatment is plotted in Fig. 2. There was a significant effect
of age and light condition on melatonin suppression. Two-
way repeated measures ANOVA revealed a significant effect
of both age (F(1,30)Z5.80, pZ0.02) and 456 nm light
(F(1,30)Z11.83, pZ0.002) on melatonin suppression.
Tukey HSD post hoc test revealed a significant reduction in
melatonin suppression in the postmenopausal subjects
following both 3.8 mW/cm2 (K1.4G5%) and 9.8 mW/cm2
(12.5G4%) 456 nm light (p!0.001 and 0.05, respectively)
compared to melatonin suppression following the same light
irradiances (18.4G4.8 and 25.5G6.4%, respectively) in
young subjects (Fig. 2). No interaction between age and light
irradiance with the 456 nm light was observed (F(1,30)Z1.25,
pZ0.27). In contrast there was no significant effect of
age (F(1,30)Z2.17, pZ0.15), light irradiance (F(1,30)Z2.89,
pZ1) or interaction (F(1,30)Z2.90, pZ1) with the 548 nm
Fig. 1. Melatonin suppression expressed as a percentage of the 0-point value (time of lights on) for young (&) and postmenopausal (B) subjects across
the four different light treatments: (a) 3.8 mW/cm2 lmax 456 nm, (b) 9.8 mW/cm
2 lmax 456 nm, (c) 28 mW/cm
2 lmax 548 nm and (d) 62 mW/cm
2 lmax
548 nm. Light exposure.
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analysis. Two-way repeated measures ANOVA of AUC
0–45 min showed an effect of both age (F(1,30)Z4.43, pZ
0.04) and 456 nm light treatment (F(1,30)Z9.82, pZ0.004)
on melatonin suppression without interaction (F(1,30)Z0.55,
pZ0.46). Tukey HSD post hoc test revealed a significant
reduction in melatonin suppression (AUC 0–45 min) in the
postmenopausal subjects following 3.8 mW/cm2 456 nm
light (p!0.01) and a non significant trend following
9.8 mW/cm2 456 nm light (pZ0.07) compared to the young
subjects. Furthermore, no effect of age (F(1,30)Z0.50, pZ
0.48), light irradiance (F(1,30)Z0.29, pZ0.59) or interaction
(F(1,30)Z0.35, pZ0.55) following exposure to 548 nm light
was noted.
A significant negative correlation was found between an
individual’s spectral lens density and melatonin suppression
following exposure to 456 nm light of 3.8 and 9.8 mW/cm2
(F(2,29)Z3.87, multiple rZK0.45; p!0.05) using multiple
regression analysis. No significant correlation was noted
between an individual’s spectral lens density and melatonin
suppression following exposure to 548 nm light.4. Discussion
This is the first demonstration that the ability of short
wavelength light to suppress melatonin is reduced with age.Although age-related changes in lens density with
consequent reduction in the transmission of short wavelength
light has been well characterised (Said and Weale, 1959;
Norren and Vos, 1974; Smith and Pokorny, 1975), this is the
first time that this phenomenon has been linked to a
physiological non-image forming light response i.e. melato-
nin suppression. Melatonin suppression was only signifi-
cantly different between the two age groups following
exposure to short wavelength light. Both decreased pupil
diameter (Verriest, 1971) and opacification of the ageing lens
(Weale, 1954; Coren and Girgus, 1972; Xu et al., 1997) may
contribute to the reduced amount of short wavelength light
reaching the retina. Ideally, knowledge of the lens density of
each study subject would be useful so that the data could be
individually corrected. Using the two-factor non-linear lens
density spectrum formula (Pokorny et al., 1987) the average
lens density was calculated for each subject. Lens density
was negatively correlated with melatonin suppression
following short wavelength treatments. There was no
correlation between lens density and melatonin suppression
following medium wavelength light exposure.
Poor repeatability of the melatonin rhythm between the
study nights was observed in 15 of the 32 subjects. The
reason for this is not clear. There was no consistent pattern
to the change in melatonin concentrations between the study
nights. Previous studies using the current protocol (Thapan
et al., 2001) did not observe this variability in the young,
Fig. 2. Average % melatonin suppression in young ( , nZ13) and
postmenopausal (,, nZ19) women across the four light treatments:
(a) lmax 456 nm: 3.8 mW/cm
2 and 9.8 mW/cm2, (b) lmax 548 nm:
28 mW/cm2 and 62 mW/cm2. *p!0.05; ***p!0.001 compared to the
corresponding young group (Tukey HSD post hoc test).
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age or simply the difficulty of taking blood samples from
elderly women may affect repeatability requires further
study.
The present study only assessed melatonin suppression
in women. Two studies (Boyce and Kennaway, 1987;
Nathan et al., 2000) have shown no significant gender
difference in melatonin suppression using a range of
intensities (200–3000 lux) of white light. These findings
were in contrast to a report which showed females had a
greater sensitivity to 2000 lux of white light in comparison to
males (Monteleone et al., 1995). In a preliminary study
comparing the response of young men and young women to
monochromatic 456 and 548 nm light, although the young
females showed reduced melatonin suppression compared to
the men, these gender differences were not statistically
significant (Skene, Middleton, Thapan, unpublished data).Thus, although it is most likely that older men would also
show reduced sensitivity to short wavelength light similar to
that demonstrated in older women, this remains to be shown.
The present results raise the question of the minimum
amount of short wavelength light required to maintain
adequate circadian synchronisation in older people. The
current study provides the first experimental evidence to
support the idea that the minimum levels of short
wavelength light needed for photic entrainment of the
circadian system would be different for young compared to
older individuals. Future studies are needed to determine
what these minimum levels might be and how these relate to
an individual’s lens density. If the ability of short
wavelength light to phase shift circadian rhythms is also
reduced in the elderly (and this is likely on the basis of the
present results), this may have important practical impli-
cations. For example, appropriate lighting adjustments may
need to be made to hospitalised and housebound elderly
who may not be exposed to sufficient amount of illumina-
tion (Campbell et al., 1988; Van Someren et al., 1997; Monk
et al., 2000). Furthermore, elderly shift workers may need
more short wavelength light of a higher intensity than
younger colleagues in order to hasten adaptation to a new
shift schedule.
The light irradiances tested in the current study (3.8 and
9.8 mW/cm2) were 10-fold lower than the average house-
hold illumination of 300 lux (100 mW/cm2). Even this low
intensity experimental light is capable of suppressing
nocturnal melatonin production, in agreement with previous
studies (Brainard et al., 2001; Thapan et al., 2001).
However, before short wavelength light can be used in
real life in repeated doses, light-induced photochemical
damage to the retina (photoretinitis), also known as blue
light hazard, needs to be assessed. Blue light hazard peaks at
440 nm and falls to 80% at 460 nm (ICNIRP, 1997).
Adjusting lighting to 460–480 nm would possibly minimise
any retinal injury while still retaining the most effective
short wavelengths of light necessary for circadian
entrainment.
In summary, we have demonstrated reduced melatonin
suppression in response to short wavelength light in older
postmenopausal women. The implications of this reduced
light sensitivity for photic entrainment of the circadian
system in older people require further study.Acknowledgements
We would like to thank Dr Victoria Revell and
Ms Selvamalar Ratnasingam for all their help during the
clinical trials. Special thanks also go to all the volunteers for
their time and dedication to the project. This research
was supported by an EU 5th Framework grant (QLK6-CT-
2000-00499).
M. Herljevic et al. / Experimental Gerontology 40 (2005) 237–242242References
Ancoli-Israel, S., 2000. Insomnia in the elderly: a review for the primary
care practitioner. Sleep 23, S36–S38.
Bliwise, D.L., 1993. Sleep in normal aging and dementia. Sleep 16, 40–81.
Boyce, P., Kennaway, D.J., 1987. Effects of light on melatonin production.
Biol. Psychiatry 22, 473–478.
Brainard, G.C., Hanifin, J.P., Greeson, J.M., Byrne, B., Glickman, G.,
Gerner, E., Rollag, M.D., 2001. Action spectrum for melatonin
regulation in humans: evidence for a novel circadian photoreceptor.
J. Neurosci. 21, 6405–6412.
Campbell, S.S., Kripke, D.F., Gillin, J.C., Hrubovcak, J.C., 1988. Exposure
to light in healthy elderly subjects and Alzheimer’s patients. Physiol.
Behav. 42, 141–144.
Coren, S., Girgus, J.S., 1972. Density of human lens pigmentation: in vivo
measures over an extended age range. Vision Res. 12, 343–346.
Dijk, D.J., Duffy, J.F., 1999. Circadian regulation of human sleep and age-
related changes in its timing, consolidation and EEG characteristics.
Ann. Med. 31, 130–140.
Dillon, J., Atherton, S.J., 1990. Time resolved spectroscopic studies on the
intact human lens. Photochem. Photobiol. 51, 465–468.
Duffy, J.F., Dijk, D.J., Klerman, E.B., Czeisler, C.A., 1998. Later
endogenous circadian temperature nadir relative to an earlier wake
time in older people. Am. J. Physiol. 275, R1478–R1487.
Fraser, S., Cowen, P., Franklin, M., Franey, C., Arendt, J., 1983. Direct
radioimmunoassay for melatonin in plasma. Clin. Chem. 29, 396–397.
Garner, B., Vazquez, S., Griffith, R., Lindner, R.A., Carver, J.A.,
Truscott, R.J., 1999. Identification of glutathionyl-3-hydroxykynure-
nine glucoside as a novel fluorophore associated with aging of the
human lens. J. Biol. Chem. 274, 20847–20854.
International Commission on Non-Ionising Radiation Protection (ICNIRP),
1997. Guidelines on limits of exposure to broad band incoherent optical
radiation. Health Phys. 73, 539–554.
Jedziniak, J.A., Kinoshita, J.H., Yates, E.M., Hocker, L.O., Benedek, G.B.,
1973. On the presence and mechanism of formation of heavy molecular
weight aggregates in human normal and cataractous lenses. Exp. Eye
Res. 15, 185–192.
Lerman, S., Kuck Jr., J.F., Borkman, R., Saker, E., 1976. Accleration of an
aging parameter (fluorogen) in the ocular lens. Ann. Ophthalmol. 8,
558–561.
Lockley, S.W., Brainard, G.C., Czeisler, C.A., 2003. High sensitivity of the
human circadian melatonin rhythm to resetting by short wavelength
light. J. Clin. Endocrinol. Metab. 88, 4502–4505.Monk, T.H., Buysse, D.J., Carrier, J., Kupfer, D.J., 2000. Inducing jet-lag in
older people: directional asymmetry. J. Sleep Res. 9, 101–116.
Monteleone, P., Esposito, G., La Rocca, A., Maj, M., 1995. Does bright
light suppress nocturnal melatonin secretion more in women than men?
J. Neural. Transm. Gen. Sect. 102, 75–80.
Nathan, P.J., Burrows, G.D., Norman, T.R., 1999. The effect of age and pre-
light melatonin concentration on the melatonin sensitivity to dim light.
Int. Clin. Psychopharmacol. 14, 189–192.
Nathan, P.J., Wyndham, E.L., Burrows, G.D., Norman, T.R., 2000. The
effect of gender on the melatonin suppression by light: a dose response
relationship. J. Neural. Transm. 107, 271–279.
Norren, D.V., Vos, J.J., 1974. Spectral transmission of the human ocular
media. Vision Res. 14, 1237–1244.
Pokorny, J., Smith, V.C., Lutze, M., 1987. Aging of the human lens. App.
Optics 26, 1437–1440.
Said, F.S., Weale, R.A., 1959. The variation with age of the spectral
transmissivity of the living human crystalline lens. Gerontologia 3,
213–231.
Skene, D.J., Swaab, D.F., 2003. Melatonin rhythmicity: effect of age and
Alzheimer’s disease. Exp. Gerontol. 38, 199–206.
Smith, V.C., Pokorny, J., 1975. Spectral sensitivity of the foveal cone
photopigments between 400 and 500 nm. Vision Res. 15, 161–171.
Thapan, K., Arendt, J., Skene, D.J., 2001. An action spectrum for melatonin
suppression: evidence for a novel non-rod, non-cone photoreceptor
system in humans. J. Physiol. 535, 261–267.
Van Someren, E.J., Kessler, A., Mirmiran, M., Swaab, D.F., 1997. Indirect
bright light improves circadian rest-activity rhythm disturbances in
demented patients. Biol. Psychiatry 41, 955–963.
Van Someren, E.J., 2000. Circadian and sleep disturbances in the elderly.
Exp. Gerontol. 35, 1229–1237.
Verriest, G., 1971. Influence of age on visual functions in humans. Bull.
Acad. R. Med. Belg. 11, 527–578.
Warman, V.L., Dijk, D.J., Warman, G.R., Arendt, J., Skene, D.J., 2003.
Phase advancing human circadian rhythms with short wavelength light.
Neurosci. Lett. 342, 37–40.
Weale, R.A., 1954. Retinal irradiation and aniseikonia. Br. J. Ophthalmol.
38, 248–249.
Weale, R.A., 1985. Human lenticular fluorescence and transmissivity, and
their effects on vision. Exp. Eye Res. 41, 457–473.
Xu, J., Pokorny, J., Smith, V.C., 1997. Optical density of the human lens.
J. Opt. Soc. Am. A. 14, 953–960.
Yu, N.T., Denagel, D.C., Pruett, P.L., Kuck Jr., J.F., 1985. Disulfide
bond formation in the eye lens. Proc. Natl Acad. Sci. USA 82,
7965–7968.
